Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 308 entries
Sorted by: Best Match Show Resources per page
[No histology, no treatment].

Bulletin du cancer

Cosset JM.
PMID: 8173181
Bull Cancer. 1993 Apr;80(4):279.

No abstract available.

Cite
Cosset JM. Pas d'histologie, pas de traitement. [No histology, no treatment]. Bull Cancer. 1993;80(4):279
Cosset, J. M. (1993). Pas d'histologie, pas de traitement. [No histology, no treatment]. Bulletin du cancer, 80(4), 279.
Cosset, J M. "Pas d'histologie, pas de traitement." [No histology, no treatment]. Bulletin du cancer vol. 80,4 (1993): 279.
Cosset JM. Pas d'histologie, pas de traitement. [No histology, no treatment]. Bull Cancer. 1993 Apr;80(4):279. French. PMID: 8173181.
Copy Download .nbib Format: NLM
Free amino acids and dipeptides in porcine muscles: differences between `red' and `white' muscles.

Meat science

Cornet M, Bousset J.
PMID: 22061854
Meat Sci. 1999 Mar;51(3):215-9. doi: 10.1016/s0309-1740(98)00104-1.

Three porcine muscles (m. longissimus dorsi, masseter and trapezius), chosen to represent the three main metabolic types, from 18 carcasses had their free amino acids and dipeptides quantified by reverse-phase high performance liquid chromatography (HPLC) in aqueous extracts derivatized...

Cite
Cornet M, Bousset J. Free amino acids and dipeptides in porcine muscles: differences between `red' and `white' muscles. Meat Sci. 1999;51(3):215-9doi: 10.1016/s0309-1740(98)00104-1.
Cornet, M., & Bousset, J. (1999). Free amino acids and dipeptides in porcine muscles: differences between `red' and `white' muscles. Meat science, 51(3), 215-9. https://doi.org/10.1016/s0309-1740(98)00104-1
Cornet, M, and Bousset, J. "Free amino acids and dipeptides in porcine muscles: differences between `red' and `white' muscles." Meat science vol. 51,3 (1999): 215-9. doi: https://doi.org/10.1016/s0309-1740(98)00104-1
Cornet M, Bousset J. Free amino acids and dipeptides in porcine muscles: differences between `red' and `white' muscles. Meat Sci. 1999 Mar;51(3):215-9. doi: 10.1016/s0309-1740(98)00104-1. PMID: 22061854.
Copy Download .nbib Format: NLM
Faculty perceptions of how community-engaged research is valued in tenure, promotion, and retention decisions.

Clinical and translational science

Nokes KM, Nelson DA, McDonald MA, Hacker K, Gosse J, Sanford B, Opel S.
PMID: 23919360
Clin Transl Sci. 2013 Aug;6(4):259-66. doi: 10.1111/cts.12077.

PURPOSE: We assessed the perceptions of community core faculty in academic medical center institutions that received Clinical and Translational Science Awards (CTSA) about how these institutions consider community-engaged scholarship (CES) when tenure, promotion, and retention decisions are made.METHOD: An...

Cite
Nokes KM, Nelson DA, McDonald MA, et al. Faculty perceptions of how community-engaged research is valued in tenure, promotion, and retention decisions. Clin Transl Sci. 2013;6(4):259-66doi: 10.1111/cts.12077.
Nokes, K. M., Nelson, D. A., McDonald, M. A., Hacker, K., Gosse, J., Sanford, B., & Opel, S. (2013). Faculty perceptions of how community-engaged research is valued in tenure, promotion, and retention decisions. Clinical and translational science, 6(4), 259-66. https://doi.org/10.1111/cts.12077
Nokes, Kathleen M, et al. "Faculty perceptions of how community-engaged research is valued in tenure, promotion, and retention decisions." Clinical and translational science vol. 6,4 (2013): 259-66. doi: https://doi.org/10.1111/cts.12077
Nokes KM, Nelson DA, McDonald MA, Hacker K, Gosse J, Sanford B, Opel S. Faculty perceptions of how community-engaged research is valued in tenure, promotion, and retention decisions. Clin Transl Sci. 2013 Aug;6(4):259-66. doi: 10.1111/cts.12077. PMID: 23919360; PMCID: PMC3740454.
Copy Download .nbib Format: NLM
Universal computation by multiparticle quantum walk.

Science (New York, N.Y.)

Childs AM, Gosset D, Webb Z.
PMID: 23413349
Science. 2013 Feb 15;339(6121):791-4. doi: 10.1126/science.1229957.

A quantum walk is a time-homogeneous quantum-mechanical process on a graph defined by analogy to classical random walk. The quantum walker is a particle that moves from a given vertex to adjacent vertices in quantum superposition. We consider a...

Cite
Childs AM, Gosset D, Webb Z. Universal computation by multiparticle quantum walk. Science. 2013;339(6121):791-4doi: 10.1126/science.1229957.
Childs, A. M., Gosset, D., & Webb, Z. (2013). Universal computation by multiparticle quantum walk. Science (New York, N.Y.), 339(6121), 791-4. https://doi.org/10.1126/science.1229957
Childs, Andrew M, et al. "Universal computation by multiparticle quantum walk." Science (New York, N.Y.) vol. 339,6121 (2013): 791-4. doi: https://doi.org/10.1126/science.1229957
Childs AM, Gosset D, Webb Z. Universal computation by multiparticle quantum walk. Science. 2013 Feb 15;339(6121):791-4. doi: 10.1126/science.1229957. PMID: 23413349.
Copy Download .nbib Format: NLM
Leveraging TSP Solver Complementarity through Machine Learning.

Evolutionary computation

Kerschke P, Kotthoff L, Bossek J, Hoos HH, Trautmann H.
PMID: 28836836
Evol Comput. 2018;26(4):597-620. doi: 10.1162/evco_a_00215. Epub 2017 Aug 24.

The Travelling Salesperson Problem (TSP) is one of the best-studied NP-hard problems. Over the years, many different solution approaches and solvers have been developed. For the first time, we directly compare five state-of-the-art inexact solvers-namely, LKH, EAX, restart variants...

Cite
Kerschke P, Kotthoff L, Bossek J, et al. Leveraging TSP Solver Complementarity through Machine Learning. Evol Comput. 2017;26(4):597-620doi: 10.1162/evco_a_00215.
Kerschke, P., Kotthoff, L., Bossek, J., Hoos, H. H., & Trautmann, H. (2018). Leveraging TSP Solver Complementarity through Machine Learning. Evolutionary computation, 26(4), 597-620. https://doi.org/10.1162/evco_a_00215
Kerschke, Pascal, et al. "Leveraging TSP Solver Complementarity through Machine Learning." Evolutionary computation vol. 26,4 (2018): 597-620. doi: https://doi.org/10.1162/evco_a_00215
Kerschke P, Kotthoff L, Bossek J, Hoos HH, Trautmann H. Leveraging TSP Solver Complementarity through Machine Learning. Evol Comput. 2018;26(4):597-620. doi: 10.1162/evco_a_00215. Epub 2017 Aug 24. PMID: 28836836.
Copy Download .nbib Format: NLM
Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study.

Reproductive biomedicine & society online

Barrenetxea G, García-Velasco JA, Aragón B, Osset J, Brosa M, López-Martínez N, Coroleu B.
PMID: 29774275
Reprod Biomed Soc Online. 2018 Feb 21;5:46-59. doi: 10.1016/j.rbms.2018.01.001. eCollection 2018 Apr.

This study presents an economic assessment of controlled ovarian stimulation in assisted reproductive technology procedures in Spain, comparing the use of corifollitropin alfa and various forms of recombinant follicle-stimulating hormone (rFSH) in women of advanced maternal age. A cost-minimization...

Cite
Barrenetxea G, García-Velasco JA, Aragón B, et al. Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study. Reprod Biomed Soc Online. 2018;5:46-59doi: 10.1016/j.rbms.2018.01.001.
Barrenetxea, G., García-Velasco, J. A., Aragón, B., Osset, J., Brosa, M., López-Martínez, N., & Coroleu, B. (2018). Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study. Reproductive biomedicine & society online, 546-59. https://doi.org/10.1016/j.rbms.2018.01.001
Barrenetxea, Gorka, et al. "Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study." Reproductive biomedicine & society online vol. 5 (2018): 46-59. doi: https://doi.org/10.1016/j.rbms.2018.01.001
Barrenetxea G, García-Velasco JA, Aragón B, Osset J, Brosa M, López-Martínez N, Coroleu B. Comparative economic study of the use of corifollitropin alfa and daily rFSH for controlled ovarian stimulation in older patients: Cost-minimization analysis based on the PURSUE study. Reprod Biomed Soc Online. 2018 Feb 21;5:46-59. doi: 10.1016/j.rbms.2018.01.001. eCollection 2018 Apr. PMID: 29774275; PMCID: PMC5952674.
Copy Download .nbib Format: NLM
Microwave Signature of Topological Andreev level Crossings in a Bismuth-based Josephson Junction.

Physical review letters

Murani A, Dassonneville B, Kasumov A, Basset J, Ferrier M, Deblock R, Guéron S, Bouchiat H.
PMID: 30848609
Phys Rev Lett. 2019 Feb 22;122(7):076802. doi: 10.1103/PhysRevLett.122.076802.

Demonstrating the topological protection of Andreev states in Josephson junctions is an experimental challenge. In particular the telltale 4π periodicity expected for the current phase relation has remained elusive, because of fast parity breaking processes. It was predicted that...

Cite
Murani A, Dassonneville B, Kasumov A, et al. Microwave Signature of Topological Andreev level Crossings in a Bismuth-based Josephson Junction. Phys Rev Lett. 2019;122(7):076802doi: 10.1103/PhysRevLett.122.076802.
Murani, A., Dassonneville, B., Kasumov, A., Basset, J., Ferrier, M., Deblock, R., Guéron, S., & Bouchiat, H. (2019). Microwave Signature of Topological Andreev level Crossings in a Bismuth-based Josephson Junction. Physical review letters, 122(7), 076802. https://doi.org/10.1103/PhysRevLett.122.076802
Murani, A, et al. "Microwave Signature of Topological Andreev level Crossings in a Bismuth-based Josephson Junction." Physical review letters vol. 122,7 (2019): 076802. doi: https://doi.org/10.1103/PhysRevLett.122.076802
Murani A, Dassonneville B, Kasumov A, Basset J, Ferrier M, Deblock R, Guéron S, Bouchiat H. Microwave Signature of Topological Andreev level Crossings in a Bismuth-based Josephson Junction. Phys Rev Lett. 2019 Feb 22;122(7):076802. doi: 10.1103/PhysRevLett.122.076802. PMID: 30848609.
Copy Download .nbib Format: NLM
In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement.

Pharmaceutics

Gunnella F, Kunisch E, Horbert V, Maenz S, Bossert J, Jandt KD, Plöger F, Kinne RW.
PMID: 31484306
Pharmaceutics. 2019 Sep 03;11(9). doi: 10.3390/pharmaceutics11090455.

Bone regeneration of sheep lumbar osteopenia is promoted by targeted delivery of bone morphogenetic proteins (BMPs) via a biodegradable, brushite-forming calcium-phosphate-cement (CPC) with stabilizing poly(l-lactide-

Cite
Gunnella F, Kunisch E, Horbert V, et al. In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement. Pharmaceutics. 2019;11(9)doi: 10.3390/pharmaceutics11090455.
Gunnella, F., Kunisch, E., Horbert, V., Maenz, S., Bossert, J., Jandt, K. D., Plöger, F., & Kinne, R. W. (2019). In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement. Pharmaceutics, 11(9), . https://doi.org/10.3390/pharmaceutics11090455
Gunnella, Francesca, et al. "In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement." Pharmaceutics vol. 11,9 (2019). doi: https://doi.org/10.3390/pharmaceutics11090455
Gunnella F, Kunisch E, Horbert V, Maenz S, Bossert J, Jandt KD, Plöger F, Kinne RW. In Vitro Release of Bioactive Bone Morphogenetic Proteins (GDF5, BB-1, and BMP-2) from a PLGA Fiber-Reinforced, Brushite-Forming Calcium Phosphate Cement. Pharmaceutics. 2019 Sep 03;11(9). doi: 10.3390/pharmaceutics11090455. PMID: 31484306; PMCID: PMC6781330.
Copy Download .nbib Format: NLM
[No title available]

Biomedical optics express

Daoudi K, Hoogenboom M, den Brok M, Eikelenboom D, Adema GJ, Fütterer JJ, de Korte CL.
PMID: 28736668
Biomed Opt Express. 2017 Mar 20;8(4):2235-2244. doi: 10.1364/BOE.8.002235. eCollection 2017 Apr 01.

The thermal effect of high intensity focused ultrasound (HIFU) has been clinically exploited over a decade, while the mechanical HIFU is still largely confined to laboratory investigations. This is in part due to the lack of adequate imaging techniques...

Cite
Daoudi K, Hoogenboom M, den Brok M, et al. . Biomed Opt Express. 2017;8(4):2235-2244doi: 10.1364/BOE.8.002235.
Daoudi, K., Hoogenboom, M., den Brok, M., Eikelenboom, D., Adema, G. J., Fütterer, J. J., & de Korte, C. L. (2017). . Biomedical optics express, 8(4), 2235-2244. https://doi.org/10.1364/BOE.8.002235
Daoudi, Khalid, et al. "." Biomedical optics express vol. 8,4 (2017): 2235-2244. doi: https://doi.org/10.1364/BOE.8.002235
Daoudi K, Hoogenboom M, den Brok M, Eikelenboom D, Adema GJ, Fütterer JJ, de Korte CL. . Biomed Opt Express. 2017 Mar 20;8(4):2235-2244. doi: 10.1364/BOE.8.002235. eCollection 2017 Apr 01. PMID: 28736668; PMCID: PMC5516825.
Copy Download .nbib Format: NLM
Re-thinking the preclinical development of GBM therapeutics.

Oncoscience

Cosset É, Weis SM, Cheresh DA.
PMID: 29556513
Oncoscience. 2018 Feb 23;5(1):11-12. doi: 10.18632/oncoscience.396. eCollection 2018 Jan.

No abstract available.

Cite
Cosset É, Weis SM, Cheresh DA. Re-thinking the preclinical development of GBM therapeutics. Oncoscience. 2018;5(1):11-12doi: 10.18632/oncoscience.396.
Cosset, �. �., Weis, S. M., & Cheresh, D. A. (2018). Re-thinking the preclinical development of GBM therapeutics. Oncoscience, 5(1), 11-12. https://doi.org/10.18632/oncoscience.396
Cosset, Érika, et al. "Re-thinking the preclinical development of GBM therapeutics." Oncoscience vol. 5,1 (2018): 11-12. doi: https://doi.org/10.18632/oncoscience.396
Cosset É, Weis SM, Cheresh DA. Re-thinking the preclinical development of GBM therapeutics. Oncoscience. 2018 Feb 23;5(1):11-12. doi: 10.18632/oncoscience.396. eCollection 2018 Jan. PMID: 29556513; PMCID: PMC5854288.
Copy Download .nbib Format: NLM
Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study.

Intensive care medicine experimental

Layios N, Delierneux C, Hego A, Huart J, Gosset C, Lecut C, Maes N, Geurts P, Joly A, Lancellotti P, Albert A, Damas P, Gothot A, Oury C.
PMID: 28699088
Intensive Care Med Exp. 2017 Dec;5(1):32. doi: 10.1186/s40635-017-0145-2. Epub 2017 Jul 12.

BACKGROUND: Platelets have been involved in both immune surveillance and host defense against severe infection. To date, whether platelet phenotype or other hemostasis components could be associated with predisposition to sepsis in critical illness remains unknown. The aim of...

Cite
Layios N, Delierneux C, Hego A, et al. Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive Care Med Exp. 2017;5(1):32doi: 10.1186/s40635-017-0145-2.
Layios, N., Delierneux, C., Hego, A., Huart, J., Gosset, C., Lecut, C., Maes, N., Geurts, P., Joly, A., Lancellotti, P., Albert, A., Damas, P., Gothot, A., & Oury, C. (2017). Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive care medicine experimental, 5(1), 32. https://doi.org/10.1186/s40635-017-0145-2
Layios, Nathalie, et al. "Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study." Intensive care medicine experimental vol. 5,1 (2017): 32. doi: https://doi.org/10.1186/s40635-017-0145-2
Layios N, Delierneux C, Hego A, Huart J, Gosset C, Lecut C, Maes N, Geurts P, Joly A, Lancellotti P, Albert A, Damas P, Gothot A, Oury C. Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study. Intensive Care Med Exp. 2017 Dec;5(1):32. doi: 10.1186/s40635-017-0145-2. Epub 2017 Jul 12. PMID: 28699088; PMCID: PMC5505890.
Copy Download .nbib Format: NLM
[Not Available].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie

Rose Dite Modestine J, Cour F, Bosset P, Vidart A, Neuzillet Y, Lebret T.
PMID: 26461645
Prog Urol. 2014 Nov;24(13):837-8. doi: 10.1016/j.purol.2014.08.120. Epub 2014 Oct 30.

No abstract available.

Cite
Rose Dite Modestine J, Cour F, Bosset P, et al. Courbe d'apprentissage de l'implantation des bandelettes sous-urétrales par voie rétro-pubienne : à propos d'une série prospective de 108 cas. [Not Available]. Prog Urol. 2014;24(13):837-8doi: 10.1016/j.purol.2014.08.120.
Rose Dite Modestine, J., Cour, F., Bosset, P., Vidart, A., Neuzillet, Y., & Lebret, T. (2014). Courbe d'apprentissage de l'implantation des bandelettes sous-urétrales par voie rétro-pubienne : à propos d'une série prospective de 108 cas. [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 24(13), 837-8. https://doi.org/10.1016/j.purol.2014.08.120
Rose Dite Modestine, J, et al. "Courbe d'apprentissage de l'implantation des bandelettes sous-urétrales par voie rétro-pubienne : à propos d'une série prospective de 108 cas." [Not Available]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie vol. 24,13 (2014): 837-8. doi: https://doi.org/10.1016/j.purol.2014.08.120
Rose Dite Modestine J, Cour F, Bosset P, Vidart A, Neuzillet Y, Lebret T. Courbe d'apprentissage de l'implantation des bandelettes sous-urétrales par voie rétro-pubienne : à propos d'une série prospective de 108 cas. [Not Available]. Prog Urol. 2014 Nov;24(13):837-8. doi: 10.1016/j.purol.2014.08.120. Epub 2014 Oct 30. French. PMID: 26461645.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 308 entries